ALP PHARM BEIJING CO., LTD. Company Profile,ALP PHARM BEIJING CO., LTD. Essential Information

Company Profile

Our Company Our Business

Year Established : 2006

Total Assets(USD) : More than 99,999,999

Total Number of Staff : 50-100

Main Competitive Advantages : International Approvals/Standards,Production Capacity,Contract Manufacturing (CRO,CMO),Quality Service

Other Competitive Advantages : ALP Pharm business was started in Dec. 2006. We began to manufacture some APIs in the partners facilities since 2007. Some of our APIs have been approved by EDQM and US FDA. Our products: Acylfulvene,Bromfenac Sodium,Captopril,Cetrorelix acetate,Cidofovir Dihydrate,Clevidipine butyrate,Dasatinib monohydrate,Eptifibatide,Istradefylline,Lanreotide Acetate,Lapatinib Ditosylate, Lurasidone Hydrochloride,Irofulven,Mesalamine,Nepafenac,Octreotide Acetate,Palonosetron Hydrochloride,Paricalcitol,Plecanatide,Polymyxin B Sulphate,Risdiplam,Stiripentol,Taurine,Teduglutide,Tranexamic Acid,Zoledronic Acid All APIs meet FDA – cGMP and EDQM compliance requirements.Tel: 86-10-56531161; Email: mary@alliancepharm.com; Website: www.alppharm.com

Patents and Copyrights : USFDA approved all the inspections for ALP Pharm´s APIs.

Business Type : Agent,Trading Company,Manufacturer

R&D Capacity : OEM

Annual Turnover(USD) : More than 99,999,999

Main Sales Markets : North America,Western Europe,Australasia,Asia,Africa

Product Range : ALP Pharm business was started in Dec. 2002. We began to manufacture some APIs in the partners facilities since 2007. Some of our APIs have been approved by EDQM and US FDA. Our products: Acylfulvene,Bromfenac Sodium,Captopril,Cetrorelix acetate,Cidofovir Dihydrate,Clevidipine butyrate,Dasatinib monohydrate,Eptifibatide,Istradefylline,Lanreotide Acetate,Lapatinib Ditosylate, Lurasidone Hydrochloride,Irofulven,Mesalamine,Nepafenac,Octreotide Acetate,Palonosetron Hydrochloride,Paricalcitol,Plecanatide,Polymyxin B Sulphate,Risdiplam,Stiripentol,Taurine,Teduglutide,Tranexamic Acid,Zoledronic Acid All APIs meet FDA – cGMP and EDQM compliance requirements.Tel: 86-10-56531161; Email: mary@alliancepharm.com; Website: www.alppharm.com

Send Inquiry

ALP Pharm business was started in Dec. 2006. We began to manufacture some APIs in the partners facilities since 2007. Some of our APIs have been approved by EDQM and US FDA. Our products: Acylfulvene,Bromfenac Sodium,Captopril,Cetrorelix acetate,Cidofovir Dihydrate,Clevidipine butyrate,Dasatinib monohydrate,Eptifibatide,Istradefylline,Lanreotide Acetate,Lapatinib Ditosylate, Lurasidone Hydrochloride,Irofulven,Mesalamine,Nepafenac,Octreotide Acetate,Palonosetron Hydrochloride,Paricalcitol,Plecanatide,Polymyxin B Sulphate,Risdiplam,Stiripentol,Taurine,Teduglutide,Tranexamic Acid,Zoledronic Acid

All APIs meet FDA – cGMP and EDQM compliance requirements.Tel: 86-10-56531161; Email: mary@alliancepharm.com; Website: www.alppharm.com

Certificates/Standards

US FDA EIR

FDA/EDQM

Company Profile of ALP PHARM BEIJING CO., LTD.

Company Profile